Circulation Reports
Online ISSN : 2434-0790
Prognostic Significance of Peripheral Monocyte Counts in Patients With Chronic Heart Failure
Atsushi NozuharaEiichiro Yamamoto Takashi KomoritaDaisuke SuetaKoichiro FujisueFumi OikeMasanobu IshiiHiroki UsukuShinsuke HanataniSatoshi ArakiHirofumi SoejimaYasushi MatsuzawaYasuhiro IzumiyaKenichi Tsujita
著者情報
ジャーナル オープンアクセス HTML 早期公開
電子付録

論文ID: CR-25-0102

詳細
抄録

Background: The pathophysiological condition between heart failure (HF) with preserved left ventricular ejection fraction (LVEF; HFpEF) and non-HFpEF is different. To elucidate the prognostic value of monocytes, as representatives of the innate immune system, we examined the association between peripheral monocyte counts and future HF-related events in patients with HF.

Methods and Results: A total of 678 patients with HF referred for hospitalization was enrolled. These patients were categorized into 2 groups according to LVEF: HFpEF, and non-HFpEF. Based on the median monocyte values, we then defined the high monocyte group as having peripheral monocyte counts ≥363/mm3in patients with non-HFpEF, and as peripheral monocyte counts ≥322/mm3in patients with HFpEF. There were 200 patients with non-HFpEF and 478 with HFpEF. Based on receiver operating characteristic analysis, patients with non-HFpEF who were in the high peripheral monocyte group had a significantly higher risk of HF-related events compared with those in the low peripheral monocyte group. In contrast, the high and low peripheral monocyte groups for patients with HFpEF had no significant difference in HF-related events. Multivariate Cox hazard analysis identified high peripheral monocyte counts as an independent and significant predictor of future HF-related events only in patients with non-HFpEF.

Conclusions: High peripheral monocyte count was an independent and incremental predictor of HF-related events in non-HFpEF, rather than in patients with HFpEF.

Fullsize Image
著者関連情報
© 2025, THE JAPANESE CIRCULATION SOCIETY

This article is licensed under a Creative Commons [Attribution-NonCommercial-NoDerivatives 4.0 International] license.
https://creativecommons.org/licenses/by-nc-nd/4.0/
前の記事 次の記事
feedback
Top